A new prospective observational study that includes over 223,000 participants from Southern Brazil has found that ivermectin reduces covid-19 mortality by 92% and hospitalizations by hospitalizations as well as infection rates. Preliminary evidence also shows that patients recover faster on ivermedin.
Thousands of lives saved in Southern Brazil using ivermectin
- In the study of confirmed COVID-19 cases, 45,716 subjects (28.7%) did not use ivermisectin, 113,844 subjects (71.3%) did use it. Irregular use was classified as dosages not exceeding 60mg.
- The study found that covid-19 infection was 49% lower for those who used it regularly compared to non-users and was 25% lower when compared to irregular users.
- Furthermore, the infection rate was 32% less for irregular users than the other groups.
The conspiracy against efficacious treatments continues, as regulatory agencies enforce criminal enterprise
- The National Institutes of Health (NIH), the Centers for Disease Control (CDC), the Food and Drug Administration (FDA) and the World Health Organization (WHO) have spent tremendous resources trying to bury evidence on the efficacy of this inexpensive medication
- Despite being vilified by the most powerful public health agencies, ivermectin has been the center focus of multiple independent studies which show that it is a more efficacious treatment for COVID-19 than the current protocol
https://www.naturalnews.com/2022-07-27-ivermectin-reduces-covid-19-mortality-new-study.html
No comments:
Post a Comment